Disclosure of Potential Conflicts of Interest
D.M.W. has received consulting fees from Merck (the manufacturer of PPV23) and receives salary support from an investigator-initiated research grant from Pfizer (the manufacturer of PCV13) to Yale University. E.D.S. has nothing to disclose.
Acknowledgments
This publication was made possible, in part, by support from CTSA Grants Number UL1 TR000142 and KL2 TR000140 from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Science (NCATS), components of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.